Behavioural Brain Research 2007-08-22

Microinjection of the delta-opioid receptor selective antagonist naltrindole 5'-isothiocyanate site specifically affects cocaine self-administration in rats responding under a progressive ratio schedule of reinforcement.

Sara Jane Ward, David C S Roberts

Index: Behav. Brain Res. 182(1) , 140-4, (2007)

Full Text: HTML

Abstract

Whether the delta-opioid receptor (DOR) system can modulate behavioral effects of cocaine remains equivocal. We examined whether site- and subtype-selective blockade of DORs within the rat mesocorticolimbic system affects cocaine self-administration. The DOR antagonist naltrindole 5'-isothiocyanate (5'-NTII; 5nmol) was microinjected into the nucleus accumbens (NAcc), ventral tegmental area (VTA), or amygdala (AMYG) in rats self-administering 1.5mg/kg cocaine under a progressive ratio (PR) schedule. Intra-NAcc 5'-NTII significantly decreased cocaine self-administration, while 5'-NTII administration into the VTA significantly increased cocaine-maintained responding. 5'-NTII administration into the AMYG produced no effect. These data support a site-specific role of DORs in cocaine's behavioral effects.


Related Compounds

Related Articles:

Alkylation of opioid receptors by 5'-naltrindole-isothiocyanate injected into the nucleus accumbens of rats: receptor selectivity and anatomical diffusion.

2006-10-01

[Synapse 60(5) , 384-91, (2006)]

Evidence for chemical differentiation of delta opioid receptor subtypes by the sulfhydryl reagent N-ethylmaleimide.

1994-07-01

[Receptor 4(2) , 81-91, (1994)]

Differential antagonism by naltrindole-5'-isothiocyanate on [3H]DSLET and [3H]DPDPE binding to striatal slices of mice.

1993-01-01

[Life Sci. 53 , 1761-1765, (1993)]

Role of spinal delta1 and delta2 opioid receptors in the antinociception produced by microinjection of L-glutamate in the ventromedial medulla of the rat.

1997-08-08

[Brain Res. 765(1) , 177-81, (1997)]

Naltrindole 5'-isothiocyanate: a nonequilibrium, highly selective delta opioid receptor antagonist.

1990-06-01

[J. Med. Chem. 33(6) , 1547-8, (1990)]

More Articles...